In vivo CRO Market Growth Analysis Report - Latest Trends, Driving Factors and Key Players Research to 2030
The study predicts the short term and long term trends that can shape up the future of the In vivo CRO market including the COVID-19 pandemic implications for In vivo CROs industry. The report presents market size forecasts across types, applications, end users and countries across regions. Strategic imperatives for development managers, decision makers and industry professionals including market trends, drivers, challenges, five forces analysis, insights on markets and companies.
The In vivo CRO market forecast report identifies growth opportunities in the market and how companies are reacting to the current market conditions. In vivo CRO Companies are focusing on improving efficiency and containing costs in current economically challenging conditions. In vivo CRO market forecast and In vivo CRO market growth is outlook through 2030.
The report reflects on predictions with 2022 as the base year and 2023- 2030 as the forecast period. The research was based on the findings of expert team of analysts analyzing the In vivo CRO market opportunities, underlying market factors, demographic and economic factors, market developments and others.
In vivo CRO industry size is estimated to register strong growth over the forecast period driven by ongoing investments in product diversification and expansion strategies in developing countries in Asia Pacific and South and Central America while opting for strengthening In vivo CRO market share in developed countries.
Scope of the research-
Global In vivo CRO Market is analyzed and forecast over the outlook period from 2023 to 2030 By Services
Rodent Based In Vivo GLP Type
Rats Based In Vivo CRO
Mice Based In Vivo CRO
Others
Non-Rodent Based In Vivo GLP Type
Hamsters Based In Vivo CRO
Guinea Pigs Based In Vivo CRO
Gerbils Based In Vivo CRO
Others Based In Vivo CRO
Global In vivo CRO Market is analyzed and forecast over the outlook period from 2023 to 2030 By type including
Non GLP
In House
Outsourcing
GLP Toxicology
In House
Outsourcing
Global In vivo CRO Market is analyzed and forecast over the outlook period from 2023 to 2030 By Indication
Autoimmune/ Inflammatory Conditions
Rheumatoid Arthritis
Multiple Sclerosis
Osteoarthritis
Irritable Bowel Syndrome
Others
Pain Management
Chronic Pain
Acute Pain
Oncology
Blood Cancer
Solid Tumor
Syngeneic Model
Patient Derived Xenograft
Xenograft
Others
CNS Conditions
Epilepsy
Parkinson’s Disease
Huntington’s Disease
Stroke
Traumatic Brain Injury
ALS
Muscle Regeneration
Others
Diabetes
Obesity
Others
Top Companies Operating in In vivo CRO market include- American Preclinical Services , Charles River Laboratories , Covance Inc. , Evotec (US) Inc. , Icon PLC , Inventiv Health , Parexel International , Pharmaceutical Product Development , 120 Quintiles , 121 Theorem Clinical Research
The In vivo CRO market forecast report identifies growth opportunities in the market and how companies are reacting to the current market conditions. In vivo CRO Companies are focusing on improving efficiency and containing costs in current economically challenging conditions. In vivo CRO market forecast and In vivo CRO market growth is outlook through 2030.
The report reflects on predictions with 2022 as the base year and 2023- 2030 as the forecast period. The research was based on the findings of expert team of analysts analyzing the In vivo CRO market opportunities, underlying market factors, demographic and economic factors, market developments and others.
In vivo CRO industry size is estimated to register strong growth over the forecast period driven by ongoing investments in product diversification and expansion strategies in developing countries in Asia Pacific and South and Central America while opting for strengthening In vivo CRO market share in developed countries.
Scope of the research-
Global In vivo CRO Market is analyzed and forecast over the outlook period from 2023 to 2030 By Services
Rodent Based In Vivo GLP Type
Rats Based In Vivo CRO
Mice Based In Vivo CRO
Others
Non-Rodent Based In Vivo GLP Type
Hamsters Based In Vivo CRO
Guinea Pigs Based In Vivo CRO
Gerbils Based In Vivo CRO
Others Based In Vivo CRO
Global In vivo CRO Market is analyzed and forecast over the outlook period from 2023 to 2030 By type including
Non GLP
In House
Outsourcing
GLP Toxicology
In House
Outsourcing
Global In vivo CRO Market is analyzed and forecast over the outlook period from 2023 to 2030 By Indication
Autoimmune/ Inflammatory Conditions
Rheumatoid Arthritis
Multiple Sclerosis
Osteoarthritis
Irritable Bowel Syndrome
Others
Pain Management
Chronic Pain
Acute Pain
Oncology
Blood Cancer
Solid Tumor
Syngeneic Model
Patient Derived Xenograft
Xenograft
Others
CNS Conditions
Epilepsy
Parkinson’s Disease
Huntington’s Disease
Stroke
Traumatic Brain Injury
ALS
Muscle Regeneration
Others
Diabetes
Obesity
Others
Top Companies Operating in In vivo CRO market include- American Preclinical Services , Charles River Laboratories , Covance Inc. , Evotec (US) Inc. , Icon PLC , Inventiv Health , Parexel International , Pharmaceutical Product Development , 120 Quintiles , 121 Theorem Clinical Research
1. TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2. EXECUTIVE SUMMARY
2.1 Report Guide
2.2 Methodology
2.3 Market Segmentation
2.4 In vivo CRO Market- Key Findings, 2022
3. STRATEGIC IMPERATIVES ON GLOBAL IN VIVO CRO MARKET
3.1 COVID-19 Impact Analysis
3.2 Market Trends- Across Types, Applications, End User Types, Countries
3.3 Insights into Main Market Categories
3.4 Market Drivers and Restraints
3.5 Growth Opportunities Critical for Future Success
3.6 Key In vivo CRO Companies
4. GLOBAL IN VIVO CRO MARKET VALUE OUTLOOK TO 2030 OUTLOOK BY SERVICES
4.1 Rodent Based In Vivo GLP Type
4.1.1 Rats Based In Vivo CRO
4.1.2 Mice Based In Vivo CRO
4.1.3 Others
4.2 Non-Rodent Based In Vivo GLP Type
4.2.1 Hamsters Based In Vivo CRO
4.2.2 Guinea Pigs Based In Vivo CRO
4.2.3 Gerbils Based In Vivo CRO
4.2.4 Others Based In Vivo CRO
5. GLOBAL IN VIVO CRO MARKET VALUE OUTLOOK TO 2030 OUTLOOK BY TYPE
5.1 Non GLP
5.1.1 In House
5.1.2 Outsourcing
5.2 GLP Toxicology
5.2.1 In House
5.2.2 Outsourcing
6. GLOBAL IN VIVO CRO MARKET VALUE OUTLOOK TO 2030 OUTLOOK BY INDICATION
6.1 Autoimmune/ Inflammatory Conditions
6.1.1 Rheumatoid Arthritis
6.1.2 Multiple Sclerosis
6.1.3 Osteoarthritis
6.1.4 Irritable Bowel Syndrome
6.1.5 Others
6.2 Pain Management
6.2.1 Chronic Pain
6.2.2 Acute Pain
6.3 Oncology
6.3.1 Blood Cancer
6.3.2 Solid Tumor
6.3.2.1 Syngeneic Model
6.3.2.2 Patient Derived Xenograft
6.3.2.3 Xenograft
6.3.3 Others
6.4 CNS Conditions
6.4.1 Epilepsy
6.4.2 Parkinson’s Disease
6.4.3 Huntington’s Disease
6.4.4 Stroke
6.4.5 Traumatic Brain Injury
6.4.6 ALS
6.4.7 Muscle Regeneration
6.4.8 Others
6.5 Diabetes
6.6 Obesity
6.7 Others
7 ASIA PACIFIC IN VIVO CRO MARKET VALUE OUTLOOK TO 2030
7.1 Leading In vivo CRO Types contributing to Asia Pacific market
7.2 Top Applications contributing to Asia Pacific In vivo CRO
7.3 Top countries contributing to Asia Pacific In vivo CRO
8 EUROPE IN VIVO CRO MARKET VALUE OUTLOOK TO 2030
8.1 Leading In vivo CRO Types contributing to Europe market
8.2 Top Applications contributing to Europe In vivo CRO
8.3 Top countries contributing to Europe In vivo CRO
9 NORTH AMERICA IN VIVO CRO MARKET VALUE OUTLOOK TO 2030
9.1 Leading In vivo CRO Types contributing to North America market
9.2 Top Applications contributing to North America In vivo CRO
9.3 Top countries contributing to North America In vivo CRO
10 SOUTH AND CENTRAL AMERICA IN VIVO CRO MARKET VALUE OUTLOOK TO 2030
10.1 Leading In vivo CRO Types contributing to South and Central America market
10.2 Top Applications contributing to South and Central America In vivo CRO
10.3 Top countries contributing to South and Central America In vivo CRO
11 MIDDLE EAST AFRICA IN VIVO CRO MARKET VALUE OUTLOOK TO 2030
11.1 Leading In vivo CRO Types contributing to Middle East Africa market
11.2 Top Applications contributing to Middle East Africa In vivo CRO
11.3 Top countries contributing to Middle East Africa In vivo CRO
12 BUSINESS PROFILES OF LEADING COMPANIES
12.1 Business Description, SWOT and Financial Analysis of Companies in In vivo CRO market
12.2 American Preclinical Services
12.3 Charles River Laboratories
12.4 Covance Inc.
12.5 Evotec (US) Inc.
12.6 Icon PLC
12.7 Inventiv Health
12.8 Parexel International
12.9 Pharmaceutical Product Development
12.10 Quintiles
12.11 Theorem Clinical Research
13 RECENT INDUSTRY DEVELOPMENTS
14 APPENDIX
14.1 OGAnalysis Expertise
14.2 Sources and Methodology
14.3 Contacts
1.1 List of Tables
1.2 List of Figures
2. EXECUTIVE SUMMARY
2.1 Report Guide
2.2 Methodology
2.3 Market Segmentation
2.4 In vivo CRO Market- Key Findings, 2022
3. STRATEGIC IMPERATIVES ON GLOBAL IN VIVO CRO MARKET
3.1 COVID-19 Impact Analysis
3.2 Market Trends- Across Types, Applications, End User Types, Countries
3.3 Insights into Main Market Categories
3.4 Market Drivers and Restraints
3.5 Growth Opportunities Critical for Future Success
3.6 Key In vivo CRO Companies
4. GLOBAL IN VIVO CRO MARKET VALUE OUTLOOK TO 2030 OUTLOOK BY SERVICES
4.1 Rodent Based In Vivo GLP Type
4.1.1 Rats Based In Vivo CRO
4.1.2 Mice Based In Vivo CRO
4.1.3 Others
4.2 Non-Rodent Based In Vivo GLP Type
4.2.1 Hamsters Based In Vivo CRO
4.2.2 Guinea Pigs Based In Vivo CRO
4.2.3 Gerbils Based In Vivo CRO
4.2.4 Others Based In Vivo CRO
5. GLOBAL IN VIVO CRO MARKET VALUE OUTLOOK TO 2030 OUTLOOK BY TYPE
5.1 Non GLP
5.1.1 In House
5.1.2 Outsourcing
5.2 GLP Toxicology
5.2.1 In House
5.2.2 Outsourcing
6. GLOBAL IN VIVO CRO MARKET VALUE OUTLOOK TO 2030 OUTLOOK BY INDICATION
6.1 Autoimmune/ Inflammatory Conditions
6.1.1 Rheumatoid Arthritis
6.1.2 Multiple Sclerosis
6.1.3 Osteoarthritis
6.1.4 Irritable Bowel Syndrome
6.1.5 Others
6.2 Pain Management
6.2.1 Chronic Pain
6.2.2 Acute Pain
6.3 Oncology
6.3.1 Blood Cancer
6.3.2 Solid Tumor
6.3.2.1 Syngeneic Model
6.3.2.2 Patient Derived Xenograft
6.3.2.3 Xenograft
6.3.3 Others
6.4 CNS Conditions
6.4.1 Epilepsy
6.4.2 Parkinson’s Disease
6.4.3 Huntington’s Disease
6.4.4 Stroke
6.4.5 Traumatic Brain Injury
6.4.6 ALS
6.4.7 Muscle Regeneration
6.4.8 Others
6.5 Diabetes
6.6 Obesity
6.7 Others
7 ASIA PACIFIC IN VIVO CRO MARKET VALUE OUTLOOK TO 2030
7.1 Leading In vivo CRO Types contributing to Asia Pacific market
7.2 Top Applications contributing to Asia Pacific In vivo CRO
7.3 Top countries contributing to Asia Pacific In vivo CRO
8 EUROPE IN VIVO CRO MARKET VALUE OUTLOOK TO 2030
8.1 Leading In vivo CRO Types contributing to Europe market
8.2 Top Applications contributing to Europe In vivo CRO
8.3 Top countries contributing to Europe In vivo CRO
9 NORTH AMERICA IN VIVO CRO MARKET VALUE OUTLOOK TO 2030
9.1 Leading In vivo CRO Types contributing to North America market
9.2 Top Applications contributing to North America In vivo CRO
9.3 Top countries contributing to North America In vivo CRO
10 SOUTH AND CENTRAL AMERICA IN VIVO CRO MARKET VALUE OUTLOOK TO 2030
10.1 Leading In vivo CRO Types contributing to South and Central America market
10.2 Top Applications contributing to South and Central America In vivo CRO
10.3 Top countries contributing to South and Central America In vivo CRO
11 MIDDLE EAST AFRICA IN VIVO CRO MARKET VALUE OUTLOOK TO 2030
11.1 Leading In vivo CRO Types contributing to Middle East Africa market
11.2 Top Applications contributing to Middle East Africa In vivo CRO
11.3 Top countries contributing to Middle East Africa In vivo CRO
12 BUSINESS PROFILES OF LEADING COMPANIES
12.1 Business Description, SWOT and Financial Analysis of Companies in In vivo CRO market
12.2 American Preclinical Services
12.3 Charles River Laboratories
12.4 Covance Inc.
12.5 Evotec (US) Inc.
12.6 Icon PLC
12.7 Inventiv Health
12.8 Parexel International
12.9 Pharmaceutical Product Development
12.10 Quintiles
12.11 Theorem Clinical Research
13 RECENT INDUSTRY DEVELOPMENTS
14 APPENDIX
14.1 OGAnalysis Expertise
14.2 Sources and Methodology
14.3 Contacts
